StockData
Telomir Pharmaceuticals, Inc. logo

Telomir Pharmaceuticals, Inc. (TELO) income statement

TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.36−0.08 (-17.24%)

Close on Nov 20, 2026Market cap $25.03MP/E –Yield –

Telomir Pharmaceuticals, Inc. financial ratios

See a number that looks wrong?